← Back to Search

Connect2BWell for Substance Use Disorder

N/A
Waitlist Available
Research Sponsored by Pro-Change Behavior Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 9 months
Awards & highlights

Study Summary

This study is evaluating whether a digital + telehealth program can help people with substance use disorders.

Eligible Conditions
  • Substance Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline in Days of Use of Most Problematic Drug at 9 Months
Secondary outcome measures
Change From Baseline in ASSIST Score for Most Problematic Drug at 9 Months
Change From Baseline in ASSIST Score for Total Substance Involvement at 9 Months
Other outcome measures
Probability of Mild or Moderate Depression Relative to Greater Levels of Depression at Baseline Compared to 9 Months

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Connect2BWell ConditionExperimental Treatment1 Intervention
The Connect2BWell program delivers feedback on SUD risk, 3 brief online intervention sessions over 3 months, and text messages for 6 months. Sessions and text messages are tailored to the patient's most problematic drug based on the ASSIST; stage of change for quitting or reducing use of that drug; and stage of change for seeking treatment, if indicated. Online sessions are followed by a dashboard-guided telehealth session with a nurse care manager. The dashboard summarizes the patient's ASSIST risk scores and stage of change data; presents patients' responses to key questions in the online session; and provides tools for collaborating with the patient to select action steps matched to risk level and stage and stage of change for seeking treatment, if indicated. The program provides a patient portal with activities, resources, and tools for tracking progress on action steps.
Group II: Comparison ConditionActive Control1 Intervention
Patients assigned to the Comparison Condition will receive a brief SBIRT session delivered via telehealth by a member of their clinic care team. The session will include the clinic's standard scripted feedback matched to level of risk for alcohol use and for other drug use; encouragement to quit; and referral to specialty treatment, if indicated.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Connect2BWell
2021
N/A
~240

Find a Location

Who is running the clinical trial?

Pro-Change Behavior SystemsLead Sponsor
16 Previous Clinical Trials
14,486 Total Patients Enrolled
Community Health Center, Inc.Industry Sponsor
5 Previous Clinical Trials
1,849 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Connect2BWell: An Evidence-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Program
2021. "Connect2BWell: An Evidence-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04745065.
~57 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top